Part 5/14:
Advocating for neither blind cuts nor unchecked expenditures, a reasoned approach would encourage the administration to perform a thorough, prior evaluation of necessary funding. As was suggested, stakeholders could be allotted a period to identify which facets of medical research are essential, thus ensuring that any financial reallocations do not jeopardize vital investigations into life-threatening diseases.